Dr. David W. Dietz, MD

Dr. Dietz practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Dietz's NPI, 1578581039, was assigned on July 17, 2006. Dr. Dietz graduated from Sidney Kimmel Medical College in 1993. Dr. Dietz holds New York license 332702.

Dr. Dietz's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Dietz's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Dietz is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Dietz to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dietz practices, 2 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Dietz's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Dietz is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Dietz's licenses on file in 4 states: New York, Ohio, Missouri and Pennsylvania.

Dmand AI lists colon removal and gastrointestinal obstruction among the conditions Dr. Dietz treats.

CMS data shows 18 Medicare services from Dr. Dietz across 1 procedure code in 2024, all of them office visits, for 55 Medicare patients. Medicare paid $591 for them. Every service was in an office.

CMS counts 55 Medicare patients who saw Dr. Dietz in 2024. The largest group is 65 to 74, with 29 patients. 64% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dietz's median patient age at 50, with 46% women.

In 2024, Dr. Dietz wrote 28 Medicare Part D claims for 13 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $15 in total drug cost. In 2021, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Dietz for performance year 2024, reported as part of a group. Dr. Dietz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dietz as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 87 papers to Dr. Dietz, published from 2004 to 2024. 2016 was the busiest year, with 6. The most frequent topics are Rectal Neoplasms, Neoadjuvant Therapy and Postoperative Complications. Dr. Dietz has published most often in Dis Colon Rectum. Dr. Dietz's most frequent co-authors are Feza H. Remzi, MD, James W. Fleshman, MD and Matthew F. Kalady, MD.

Dmand AI links Dr. Dietz to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 27 general payments to Dr. Dietz from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Medical Device Business Services, Inc. paid the most, $24,894.

Dmand AI lists 4 awards for Dr. Dietz, most recently America's Top Doctors in 2014.

Dr. Dietz graduated from Sidney Kimmel Medical College in 1993. Dr. Dietz is a member of ACS.

Dr. Dietz is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.